Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients

NCT00252785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Budesonide/Formoterol
DRUG: Budesonide
DRUG: Theophylline

Sponsor

AstraZeneca